查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1498736

個人化醫療市場，按產品、按應用、按最終用戶和按地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

Personalized Medicine Market, By Product, By Application, By End User, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 325 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2023 年個人化醫療市場規模為 5,719.562 億美元，2024 年至 2032 年複合年成長率為 8.00%。

個人化醫療市場-市場動態

越來越多的人患有慢性病，推動市場成長

慢性病幾乎是每個國家的全球主要議題。全世界有許多人因治療一種或多種慢性疾病而遭受痛苦。根據美國癌症研究協會 (AACR) 的預測，到 2040 年，僅在美國就會發現超過 230 萬個新癌症病例。癌症病例；然而，實際發生率預計將高出 1.5 至 3 倍。此外，據世界衛生組織 (WHO) 稱，全球估計有 4.22 億人患有糖尿病，每年導致 150 萬人死亡。在過去的幾十年中，糖尿病的發生率和盛行率逐漸增加。因此，糖尿病、癌症等慢性疾病病例的不斷增加預計將在預測期內推動對個人化醫療的需求。

個人化醫療市場 - 關鍵見解

根據我們的研究分析師分享的分析，預計全球市場在預測期內（2024-2032 年）每年將以 8.00% 左右的複合年成長率成長

根據產品細分，個人化醫療診斷類別預計將在 2023 年呈現最大市場佔有率

從應用細分來看，腫瘤學類別是2023年的主導類型

按地區分類，北美是 2023 年的主要收入來源

個人化醫療市場-細分分析：

全球個人化醫療市場根據產品、應用、最終用戶和地區進行細分。

市場依產品分為兩類：個人化醫學診斷（基因檢測、DTC診斷等）及個人化醫學治療（藥品、基因組醫學、醫療器材）。由於糖尿病、癌症和心血管疾病等慢性疾病的成本不斷上升，以及對識別這些疾病的個人化醫療診斷的需求隨之增加，個人化醫療診斷類別在市場上佔據主導地位。此外，隨著越來越多的個人和醫療保健專業人員意識到先進的個人化醫療選擇，該市場正在不斷成長。

根據最終用戶，市場分為以下幾類：醫院和臨床護理、診斷公司和測試設施、學術研究所和研究實驗室、合約研究組織、生物和健康資訊公司等。醫院和臨床護理類別在市場中佔據主導地位，並可能在預測期內保持其主導地位。在整個預期期間推動該細分市場成長的主要成長因素之一是，由於糖尿病、癌症、心血管疾病和其他疾病等慢性疾病的盛行率不斷上升，醫院對個人化醫療的需求不斷成長。此外，有利的報銷方案以及發展中國家醫療保健投資的增加推動了個人化醫療市場的不斷成長。

個人化醫療市場-地理洞察

從地理來看，該市場廣泛分佈於北美、拉丁美洲、歐洲、亞太、中東和非洲地區。這些區域根據開展業務的國家進一步分類。

在預測期內，預計北美將佔據全球個人化醫療市場的最大佔有率。大型製藥公司和研究機構對此表示支持。新藥物的發現和對某些疾病的研究是相關的，因為目前建議個人化治療來治療多種疾病。用於診斷目的的客製化醫療領域最近取得了進展。例如，2021 年 1 月，Illumina, Inc. 創建了 TruSight Oncology 500 (TSO 500) 檢測方法，可以使用腫瘤區域的核酸有效識別多達 523 種癌症生物標記。

此外，預計亞太地區的個人化醫療市場將以全球最快的速度擴張。該地區慢性病發病率的上升和老年人口的增加正在推動市場的擴張。此外，在整個預測期內，亞洲國家研發投資的增加、醫療保健支出的增加、醫療保健意識的提高以及新診斷技術的採用預計將推動整個地區的市場擴張。

個人化醫療市場-競爭格局：

全球個人化醫療市場由許多致力於擴大市場佔有率的大大小小的公司組成。該行業可能具有一定的競爭性。由於治療慢性疾病（包括糖尿病、癌症和其他疾病）對個人化醫療的需求不斷成長，預計市場將在整個預測期內迅速擴張。 GE Healthcare、Illumina, Inc.、Abbott、Dako A/S 和 International Business Machines Corporation (IBM) 等製藥公司積極參與客製化醫療領域，正在加速將基因組資訊轉化為有用的患者治療方法。此外，重要的聯盟和夥伴關係、技術進步以及新產品的推出可能將在未來幾年支持市場擴張。

最近的發展：

2023 年 9 月：當路德維希癌症研究所的研究人員將 ACT 與客製化的癌症疫苗結合使用時，晚期卵巢癌患者獲得了更好的結果。令人驚訝的是，17 名患者中有 12 名在接受聯合藥物治療三個月後病情得到控制。這意味著治療有效地控制了疾病。

2023 年 6 月：在核子醫學和分子影像學會 (SNMMI) 2023 年年會上，GE 醫療展示了最新的尖端技術和診斷技術。 GE HealthCare 強調了治療診斷學，這是一種將客製化醫學與診斷影像相結合的新穎策略。

2023年2月：埃森哲透過埃森哲創投公司對尖端人工智慧和科技新創公司Ocean Genomics進行了大量策略性投資。總部位於匹茲堡的 Ocean Genomics 開發了先進的工具來建模和理解 mRNA 變異和變化。由於這項技術，現在可以更準確地預測患者對藥物的生物反應。

目錄

第1章：個人化醫療市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 個人化醫療市場片段（按產品）
    • 按應用分類的個人化醫療市場片段
    • 最終用戶的個人化醫療市場片段
    • 按國家/地區分類的個人化醫療市場摘要
    • 按地區分類的個人化醫療市場片段
  • 競爭洞察

第 3 章：個人化醫療主要市場趨勢

  • 個性化醫療市場促進因素
    • 市場促進因素的影響分析
  • 個人化醫療市場限制
    • 市場限制影響分析
  • 個人化醫療市場機會
  • 個人化醫療市場未來趨勢

第 4 章：個人化醫療產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：個人化醫療市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：個人化醫療市場格局

  • 個人化醫療市場佔有率分析，2023 年
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：個人化醫療市場 - 按產品

  • 概述
    • 按產品分類的細分市場佔有率分析
    • 個性化醫療診斷
      • 基因檢測
      • 故障碼診斷
      • 其他
    • 個人化醫學治療
      • 製藥
      • 基因組醫學
      • 醫療設備

第 8 章：個人化醫療市場 - 按應用

  • 概述
    • 按應用分類的細分市場佔有率分析
    • 腫瘤學
    • 神經病學
    • 心臟病學
    • 抗病毒劑
    • 精神病學
    • 免疫學
    • 其他

第 9 章：個人化醫療市場 - 按最終用戶

  • 概述
    • 按最終用戶分類的細分市場佔有率分析
    • 醫院和臨床護理
    • 診斷公司和檢測設施
    • 學術研究所和研究實驗室
    • 合約研究組織
    • 生物與健康資訊公司
    • 其他

第 10 章：個人化醫療市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美個人化醫療主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按產品）
    • 北美市場規模和預測（按應用）
    • 北美市場規模和預測（按最終用戶）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲個人化醫療主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模和預測（按產品）
    • 歐洲市場規模和預測（按應用）
    • 歐洲市場規模和預測（按最終用戶）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區個人化醫療主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區市場規模與預測（按產品）
    • 亞太地區市場規模與預測（按應用）
    • 亞太地區市場規模和預測（按最終用戶）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲個人化醫療主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模與預測（按產品）
    • 拉丁美洲市場規模與預測（按應用）
    • 拉丁美洲市場規模和預測（按最終用戶）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲個人化醫療主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按產品）
    • 中東和非洲市場規模及預測（按應用）
    • 中東和非洲市場規模及預測（按最終用戶）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 11 章：主要供應商分析 - 個人化醫療產業

  • 競爭儀表板
  • 公司簡介
    • GE Healthcare
    • Illumina, Inc.
    • Abbott
    • Dako A/S
    • International Business Machines Corporation (IBM)
    • Genelex
    • ASURAGEN, INC.
    • Danaher Corporation (Cepheid, Inc.)
    • Decode Genetics, Inc.
    • QIAGEN
    • Exagen Inc.
    • Exact Sciences Corporation
    • Celera Diagnostics LLC.
    • Biogen
    • Precision Biologics
    • Genentech, Inc.
    • 23andMe, Inc.
    • Others

第 12 章：360 度分析師視角

第 13 章：附錄

  • 研究方法論
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
Product Code: ANV2905

REPORT HIGHLIGHT

Personalized Medicine Market size was valued at USD 5,71,956.2 Million in 2023, expanding at a CAGR of 8.00% from 2024 to 2032.

Treatment that is tailored to each patient's unique physiognomies is known as personalized medicine. With a focus on patient data, customized medications, sophisticated analytics, and the understanding and management of diseases, personalized medicine has great potential to shift and transform the healthcare sector. Science and technology are evolving, particularly in the areas of disease description, medication development, and treatment recommendation in personalized medicine. The idea of personalized medicine has surfaced in the last ten years as a result of growing breakthroughs in genomic and proteomic science. These advancements have fueled the creation of targeted diagnostics and therapeutics that use an individual's genetic makeup to create a more individualized approach to healthcare.

Personalized Medicine Market- Market Dynamics

Growing Numbers of People are Suffering from Chronic Illnesses to Propel Market Growth

Chronic illnesses are becoming a major global concern in practically every nation. Numerous people worldwide experience suffering as a result of managing one or more chronic diseases. According to projections made by the American Association for Cancer Research (AACR), more than 2.3 million new cancer cases will be discovered in the US alone by the year 2040. Furthermore, according to a study conducted by the Federation of Indian Chambers of Commerce & Industry (FICCI), 19 to 20 lakh cases of cancer will be reported in India in 2022; however, the true incidence is predicted to be 1.5 to 3 times higher. Moreover, an estimated 422 million people worldwide are estimated to have diabetes, which causes 1.5 million deaths annually, according to the World Health Organization (WHO). Diabetes has gradually increased in incidence and prevalence during the last few decades. The growing cases of chronic illnesses such as diabetes, cancer, and so on is therefore anticipated to drive the demand for personalized medicine during the forecast period.

Personalized Medicine Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.00% over the forecast period (2024-2032)

Based on product segmentation, the personalized medicine diagnostics category was predicted to show maximum market share in the year 2023

Based on application segmentation, the oncology category was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Personalized Medicine Market- Segmentation Analysis:

The Global Personalized Medicine Market is segmented on the basis of Product, Application, End User, and Region.

The market is divided into two categories based on product: Personalized Medicine Diagnostics (Genetic Testing, DTC Diagnostics, Others) and Personalized Medicine Therapeutics (Pharmaceutical, Genomic Medicine, Medical Devices). The Personalized Medicine Diagnostics category dominates the market due to the rising cost of chronic illnesses, including diabetes, cancer, and cardiovascular disease, as well as the ensuing increase in demand for diagnostics in personalized medicine to identify these conditions. Additionally, the market is growing as more individuals and healthcare professionals become aware of advanced personalized medical options.

The market is divided into the following categories based on end-user: Hospitals And Clinical Care, Diagnostic Companies And Testing Facilities, Academic Research Institutes And Research Laboratories, Contract Research Organizations, Bio And Health Informatics Companies, and Others. The Hospitals And Clinical Care category dominates the market and is likely to maintain its dominance during the forecast period. One of the main growth factors propelling the segment's growth throughout the anticipated period is the rising need for personalized medicine in hospitals as a result of the rising prevalence of chronic diseases like diabetes, cancer, cardiovascular diseases, and other disorders. Additionally, the growing section of the personalized medicine market is being driven by advantageous reimbursement scenarios in conjunction with increased healthcare investments in developing nations.

Personalized Medicine Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Over the course of the forecast period, North America is anticipated to hold the greatest share of the global market for personalized medicine. Large pharmaceutical firms and research organisations have supported this. Discovery of new medications and study on certain ailments are connected since personalised therapy is presently recommended for treating many sorts of illnesses. There have been recent advancements in the field of customised medicine for diagnostic purposes. For instance, in January 2021, Illumina, Inc. created the TruSight Oncology 500 (TSO 500) assay, which can effectively identify up to 523 cancer biomarkers using nucleic acids from the tumor region.

In addition, the personalized medicine market is anticipated to expand at the fastest rate in the world during the projected period in Asia Pacific. The rising incidence of chronic diseases and the growing senior population in the area are driving the market's expansion. Additionally, throughout the projection period, rising R&D investment among Asian countries, rising healthcare expenditures, a rise in healthcare awareness, and the adoption of new diagnostic techniques are anticipated to propel market expansion throughout the region.

Personalized Medicine Market- Competitive Landscape:

The global market for personalized medicine is made up of a number of big and small companies that are focusing on expanding their market share. The industry may be characterized as being somewhat competitive. Due to the growing need for personalized medicine in the treatment of chronic diseases, including diabetes, cancer, and other conditions, the market is anticipated to expand rapidly throughout the forecast period. Pharmaceutical companies such as GE Healthcare, Illumina, Inc., Abbott, Dako A/S, and International Business Machines Corporation (IBM), among others, have aggressive involvement in the customized medicine space is hastening the conversion of genomic information into useful patient treatments. Furthermore, significant alliances and partnerships, technological advancements, and the introduction of new goods are probably going to support market expansion in the years to come.

Recent Developments:

September 2023: Patients with advanced ovarian cancer had better results when researchers at the Ludwig Institute for Cancer Research paired ACT with a customized cancer vaccination. Surprisingly, 12 out of 17 patients experienced illness control after three months of receiving the combo medication. This implies that the treatment effectively managed the disease.

June 2023: At the 2023 annual conference of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), GE HealthCare showcased new and cutting-edge technologies and diagnostics. Theranostics, a novel strategy that combines tailored medicine with diagnostic imaging, was highlighted by GE HealthCare.

February 2023: Through Accenture Ventures, Accenture made a sizable strategic investment in Ocean Genomics, a cutting-edge AI and technology startup. Pittsburgh-based Ocean Genomics has created advanced tools for modeling and comprehending mRNA variations and alterations. A patient's biological reaction to a medication can now be predicted with greater accuracy because of this technology.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PERSONALIZED MEDICINE MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

GE Healthcare

Illumina, Inc.

Abbott

Dako A/S

International Business Machines Corporation (IBM)

Genelex

ASURAGEN, INC.

Danaher Corporation (Cepheid, Inc.)

Decode Genetics, Inc.

QIAGEN

Exagen Inc.

Exact Sciences Corporation

Celera Diagnostics LLC.

Biogen

Precision Biologics

Genentech, Inc.

23andMe, Inc.

Others

GLOBAL PERSONALIZED MEDICINE MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032

  • Personalized Medicine Diagnostics
  • Genetic Testing
  • DTC Diagnostics
  • Others
  • Personalized Medicine Therapeutics
  • Pharmaceutical
  • Genomic Medicine
  • Medical Devices

GLOBAL PERSONALIZED MEDICINE MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Oncology
  • Neurology
  • Cardiology
  • Antiviral
  • Psychiatry
  • Immunology
  • Others

GLOBAL PERSONALIZED MEDICINE MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals And Clinical Care
  • Diagnostic Companies And Testing Facilities
  • Academic Research Institutes And Research Laboratories
  • Contract Research Organizations
  • Bio And Health Informatics Companies
  • Others

GLOBAL PERSONALIZED MEDICINE MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Personalized Medicine Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Personalized Medicine Market Snippet by Product
    • 2.1.2. Personalized Medicine Market Snippet by Application
    • 2.1.3. Personalized Medicine Market Snippet by End User
    • 2.1.4. Personalized Medicine Market Snippet by Country
    • 2.1.5. Personalized Medicine Market Snippet by Region
  • 2.2. Competitive Insights

3. Personalized Medicine Key Market Trends

  • 3.1. Personalized Medicine Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Personalized Medicine Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Personalized Medicine Market Opportunities
  • 3.4. Personalized Medicine Market Future Trends

4. Personalized Medicine Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Personalized Medicine Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Personalized Medicine Market Landscape

  • 6.1. Personalized Medicine Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Personalized Medicine Market - By Product

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product, 2023 & 2032 (%)
    • 7.1.2. Personalized Medicine Diagnostics
      • 7.1.2.1. Genetic Testing
      • 7.1.2.2. DTC Diagnostics
      • 7.1.2.3. Others
    • 7.1.3. Personalized Medicine Therapeutics
      • 7.1.3.1. Pharmaceutical
      • 7.1.3.2. Genomic Medicine
      • 7.1.3.3. Medical Devices

8. Personalized Medicine Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2. Oncology
    • 8.1.3. Neurology
    • 8.1.4. Cardiology
    • 8.1.5. Antiviral
    • 8.1.6. Psychiatry
    • 8.1.7. Immunology
    • 8.1.8. Others

9. Personalized Medicine Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2023 & 2032 (%)
    • 9.1.2. Hospitals And Clinical Care
    • 9.1.3. Diagnostic Companies And Testing Facilities
    • 9.1.4. Academic Research Institutes And Research Laboratories
    • 9.1.5. Contract Research Organizations
    • 9.1.6. Bio And Health Informatics Companies
    • 9.1.7. Others

10. Personalized Medicine Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Personalized Medicine Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Personalized Medicine Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Personalized Medicine Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Personalized Medicine Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Personalized Medicine Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Personalized Medicine Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. GE Healthcare
    • 11.2.2. Illumina, Inc.
    • 11.2.3. Abbott
    • 11.2.4. Dako A/S
    • 11.2.5. International Business Machines Corporation (IBM)
    • 11.2.6. Genelex
    • 11.2.7. ASURAGEN, INC.
    • 11.2.8. Danaher Corporation (Cepheid, Inc.)
    • 11.2.9. Decode Genetics, Inc.
    • 11.2.10. QIAGEN
    • 11.2.11. Exagen Inc.
    • 11.2.12. Exact Sciences Corporation
    • 11.2.13. Celera Diagnostics LLC.
    • 11.2.14. Biogen
    • 11.2.15. Precision Biologics
    • 11.2.16. Genentech, Inc.
    • 11.2.17. 23andMe, Inc.
    • 11.2.18. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Personalized Medicine Market: Product Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Product
  • TABLE Global Personalized Medicine Market, by Product 2019-2032 (USD Million)
  • TABLE Personalized Medicine Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Personalized Medicine Market, by Application 2019-2032 (USD Million)
  • TABLE Personalized Medicine Market: End User Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End User
  • TABLE Global Personalized Medicine Market, by End User 2019-2032 (USD Million)
  • TABLE Personalized Medicine Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Personalized Medicine Market, by Region 2019-2032 (USD Million)
  • TABLE North America Personalized Medicine Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Personalized Medicine Market, by Product, 2019-2032 (USD Million)
  • TABLE North America Personalized Medicine Market, by Application, 2019-2032 (USD Million)
  • TABLE North America Personalized Medicine Market, by End User, 2019-2032 (USD Million)
  • TABLE Europe Personalized Medicine Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Personalized Medicine Market, by Product, 2019-2032 (USD Million)
  • TABLE Europe Personalized Medicine Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe Personalized Medicine Market, by End User, 2019-2032 (USD Million)
  • TABLE Asia Pacific Personalized Medicine Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Personalized Medicine Market, by Product, 2019-2032 (USD Million)
  • TABLE Asia Pacific Personalized Medicine Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific Personalized Medicine Market, by End User, 2019-2032 (USD Million)
  • TABLE Latin America Personalized Medicine Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Personalized Medicine Market, by Product, 2019-2032 (USD Million)
  • TABLE Latin America Personalized Medicine Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America Personalized Medicine Market, by End User, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Personalized Medicine Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Personalized Medicine Market, by Product, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Personalized Medicine Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Personalized Medicine Market, by End User, 2019-2032 (USD Million)